Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation.
about
Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine PhysiciansUnderuse of anticoagulation in patients with atrial fibrillation.Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding.Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings
P2860
Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cost-Effectiveness of Novel Or ...... -Valvular Atrial Fibrillation.
@en
type
label
Cost-Effectiveness of Novel Or ...... -Valvular Atrial Fibrillation.
@en
prefLabel
Cost-Effectiveness of Novel Or ...... -Valvular Atrial Fibrillation.
@en
P2860
P1476
Cost-Effectiveness of Novel Or ...... -Valvular Atrial Fibrillation.
@en
P2093
Harindra C Wijeysundera
Sheldon M Singh
P2860
P2888
P356
10.1007/S11886-015-0618-4
P577
2015-08-01T00:00:00Z
P6179
1019823920